Sacchi S - Search Results

1

Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L. Gruppo Italiano Malattie Mieloproliferative Croniche(GIMMC).

Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, Baravelli S, Lazzarino M, Finazzi G. Sacchi S, et al. Haematologica. 2000 May;85(5):492-5. Haematologica. 2000. PMID: 10800165

2

Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment.

Sacchi S, Tabilio A, Leoni P, Riccardi A, Vecchi A, Messora C, Bensi L, Falzetti F, Rupoli S, Ucci G, et al. Sacchi S, et al. Ann Hematol. 1993 May;66(5):245-6. doi: 10.1007/BF01738473. Ann Hematol. 1993. PMID: 8507719

3

All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi).

Sacchi S, Russo D, Avvisati G, Dastoli G, Lazzarino M, Pelicci PG, Bonora MR, Visani G, Grassi C, Iacona I, Luzzi L, Vanzanelli P. Sacchi S, et al. Haematologica. 1997 Jan-Feb;82(1):106-21. Haematologica. 1997. PMID: 9107096 Free article. Review.

4

Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on ET.

Sacchi S, Gugliotta L, Papineschi F, Liberati AM, Rupoli S, Delfini C, Ruggeri M, Cavanna L, Bucalossi A, Benedetti E, Ferrandina C, Vinci G, Morselli M, Torelli G. Sacchi S, et al. Leukemia. 1998 Mar;12(3):289-94. doi: 10.1038/sj.leu.2400931. Leukemia. 1998. PMID: 9529121 Clinical Trial.

5

Clinical activity and safety of combination immunotherapy with IFN-alpha 2a and Rituximab in patients with relapsed low grade non-Hodgkin's lymphoma.

Sacchi S, Federico M, Vitolo U, Boccomini C, Vallisa D, Baldini L, Petrini M, Rupoli S, Di Raimondo F, Merli F, Liso V, Tabilio A, Saglio G, Vinci G, Brugiatelli M, Dastoli G; GISL. Sacchi S, et al. Haematologica. 2001 Sep;86(9):951-8. Haematologica. 2001. PMID: 11532623 Free article. Clinical Trial.

6

Interferon alpha-2b in the long-term treatment of essential thrombocythemia.

Sacchi S, Tabilio A, Leoni P, Riccardi A, Vecchi A, Messora C, Falzetti F, Rupoli S, Ucci G, Martelli MF. Sacchi S, et al. Ann Hematol. 1991 Oct;63(4):206-9. doi: 10.1007/BF01703444. Ann Hematol. 1991. PMID: 1932299

7

Myelodysplastic transformation in a case of essential thrombocythemia treated with pipobroman.

Messora C, Bensi L, Vanzanelli P, Temperani P, Carotenuto M, Sacchi S. Messora C, et al. Among authors: sacchi s. Haematologica. 1996 Jan-Feb;81(1):51-3. Haematologica. 1996. PMID: 8900853

8

Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.

Fiorani C, Vinci G, Sacchi S, Bonaccorsi G, Artusi T. Fiorani C, et al. Among authors: sacchi s. Clin Lymphoma. 2001 Jun;2(1):29-37; discussion 38-9. doi: 10.3816/clm.2001.n.009. Clin Lymphoma. 2001. PMID: 11707867 Review.

9

Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab.

Sacchi S, Federico M, Dastoli G, Fiorani C, Vinci G, Clò V, Casolari B. Sacchi S, et al. Crit Rev Oncol Hematol. 2001 Jan;37(1):13-25. doi: 10.1016/s1040-8428(00)00069-x. Crit Rev Oncol Hematol. 2001. PMID: 11164715 Review.

10

Bcl-2 oncoprotein expression in acute myeloid leukemia.

Bensi L, Longo R, Vecchi A, Messora C, Garagnani L, Bernardi S, Tamassia MG, Sacchi S. Bensi L, et al. Among authors: sacchi s. Haematologica. 1995 Mar-Apr;80(2):98-102. Haematologica. 1995. PMID: 7628759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters